Newsroom press releases

19/12/16 - 10:00

Co-optation of a Director (333.18 KB)

Financial Data

Download

10/11/16 - 1:00

DIASORIN GROUP REPORTS CONTINUED GROWTH IN REVENUES AND PROFITABILITY IN THE THIRD QUARTER 2016 (1.05 MB)

Financial Data

Download

02/11/16 - 1:00

DIASORIN LAUNCHES ITS FIRST MOLECULAR TEST WITH THE NEW BUSINESS DIVISION, DIASORIN MOLECULAR: THE NEW SIMPLEXA C. DIFFICILE DIRECT MOLECULAR TEST (141.53 KB)

Products Molecular

Download

30/08/16 - 2:00

DiaSorin and Beckman Coulter form strategic partnership to bring the LIAISON XL hepatitis and HIV products to the U.S. market (404.63 KB)

Acquisition / Partnership

Download

22/08/16 - 2:00

DIASORIN PARTNERS WITH HHS TO FACE THE ZIKA EMERGENCY (158.39 KB)

Products Immunodiagnostic

Download

04/08/16 - 2:00

The Board of Directors approves results for H1'16 (697.16 KB)

Financial Data

Download

28/07/16 - 2:00

DiaSorin starts selling Vitamin D in Japan (724.4 KB)

Products Immunodiagnostic

Download

14/07/16 - 2:00

DiaSorin increases diagnostic test menu for molecular screening of Acute Myeloid Leukemia (278.18 KB)

Products Molecular

Download

10/06/16 - 2:00

Weekly report treasury shares buy-back (289.83 KB)

Financial Data

Download

10/06/16 - 2:00

Conclusion buy-back plan (367.77 KB)

Financial Data

Download

07/06/16 - 2:00

DiaSorin launches the new Helicobacter pylori IgG CLIA test (518.61 KB)

Products Immunodiagnostic

Download

03/06/16 - 2:00

Weekly report treasury shares buy-back (290.21 KB)

Financial Data

Download

30/05/16 - 2:00

Notice filing By-Laws and publication operating procedures for loyalty shares (277.79 KB)

Financial Data

Download

27/05/16 - 2:00

Weekly report treasury shares buy-back (289.34 KB)

Financial Data

Download

20/05/16 - 2:00

Weekly report treasury shares buy-back (290.09 KB)

Financial Data

Download

13/05/16 - 2:00

Acquisition of Focus Diagnostics' Molecular and Immunoassay Product Business (350.22 KB)

Acquisition / Partnership

Download

12/05/16 - 2:00

Start up treasury shares buy-back plan (305.9 KB)

Financial Data

Download

09/05/16 - 2:00

The Board of Directors approves the results for Q1'16 (632.78 KB)

Financial Data

Download

28/04/16 - 2:00

Shareholders' Meeting FY 2015 (365.15 KB)

Financial Data

Download

30/03/16 - 2:00

DiaSorin to acquire Focus Diagnostics' Molecular and Immunoassay Product Business (133.62 KB)

Acquisition / Partnership

Download

09/03/16 - 1:00

The Board of Directors approves the results for FY'15 (785.08 KB)

Financial Data

Download

24/12/09 - 1:00

Financial instruments to employees (26.76 KB)

Financial Data

Download

30/10/09 - 1:00

The BoD approves Q3'09 results (212.92 KB)

Financial Data

Download

12/10/09 - 2:00

Strengthening of group's R&D team (99.72 KB)

Other

Download

08/10/09 - 2:00

2009 Financial calendar update (97.3 KB)

Financial Data

Download

05/10/09 - 2:00

Financial instruments to employees (27.08 KB)

Financial Data

Download

06/08/09 - 2:00

The BoD approves H1'09 results (214.79 KB)

Financial Data

Download

08/06/09 - 2:00

2009 Financial calendar update (97.33 KB)

Financial Data

Download

18/05/09 - 2:00

Financial instruments to employees (26.65 KB)

Financial Data

Download

10/04/09 - 2:00

Corporate Governance Report at December 2008. (97.57 KB)

Financial Data

Download

08/04/09 - 2:00

2009 Financial calendar update (103.88 KB)

Financial Data

Download

19/03/09 - 1:00

The BoD approves FY 2008 results (221.59 KB)

Financial Data

Download

20/02/09 - 1:00

Financial instruments to employees (26.39 KB)

Financial Data

Download

13/02/09 - 1:00

The BoD approves Q4'08 results (170.79 KB)

Financial Data

Download

28/01/09 - 1:00

2009 Financial calendar (93.96 KB)

Financial Data

Download

08/01/09 - 1:00

FDA clearance to five LIAISON products (96.84 KB)

Products Immunodiagnostic

Download

Newsroom press releases

Select year

Newsroom press category

Co-optation of a Director (333.18 KB)

DIASORIN GROUP REPORTS CONTINUED GROWTH IN REVENUES AND PROFITABILITY IN THE THIRD QUARTER 2016 (1.05 MB)

DIASORIN LAUNCHES ITS FIRST MOLECULAR TEST WITH THE NEW BUSINESS DIVISION, DIASORIN MOLECULAR: THE NEW SIMPLEXA C. DIFFICILE DIRECT MOLECULAR TEST (141.53 KB)

DiaSorin and Beckman Coulter form strategic partnership to bring the LIAISON XL hepatitis and HIV products to the U.S. market (404.63 KB)

DIASORIN PARTNERS WITH HHS TO FACE THE ZIKA EMERGENCY (158.39 KB)

The Board of Directors approves results for H1'16 (697.16 KB)

DiaSorin starts selling Vitamin D in Japan (724.4 KB)

DiaSorin increases diagnostic test menu for molecular screening of Acute Myeloid Leukemia (278.18 KB)

Weekly report treasury shares buy-back (289.83 KB)

Conclusion buy-back plan (367.77 KB)

DiaSorin launches the new Helicobacter pylori IgG CLIA test (518.61 KB)

Weekly report treasury shares buy-back (290.21 KB)

Notice filing By-Laws and publication operating procedures for loyalty shares (277.79 KB)

Weekly report treasury shares buy-back (289.34 KB)

Weekly report treasury shares buy-back (290.09 KB)

Acquisition of Focus Diagnostics' Molecular and Immunoassay Product Business (350.22 KB)

Start up treasury shares buy-back plan (305.9 KB)

The Board of Directors approves the results for Q1'16 (632.78 KB)

Shareholders' Meeting FY 2015 (365.15 KB)

DiaSorin to acquire Focus Diagnostics' Molecular and Immunoassay Product Business (133.62 KB)

The Board of Directors approves the results for FY'15 (785.08 KB)

Financial instruments to employees (26.76 KB)

The BoD approves Q3'09 results (212.92 KB)

Strengthening of group's R&D team (99.72 KB)

2009 Financial calendar update (97.3 KB)

Financial instruments to employees (27.08 KB)

The BoD approves H1'09 results (214.79 KB)

2009 Financial calendar update (97.33 KB)

Financial instruments to employees (26.65 KB)

Corporate Governance Report at December 2008. (97.57 KB)

2009 Financial calendar update (103.88 KB)

The BoD approves FY 2008 results (221.59 KB)

Financial instruments to employees (26.39 KB)

The BoD approves Q4'08 results (170.79 KB)

2009 Financial calendar (93.96 KB)

FDA clearance to five LIAISON products (96.84 KB)

Price Sensitive